Peptidyl-threonine modification

pathway activity — cross-omics
GO:0018210Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-threonine modification pathway is significantly associated with the protein abundance of multiple proteins, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are LOX, MMP14, and RPL5, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-threonine modification activity versus LOX in OV (Pearson r = 0.31).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVLOX →+0.661+0.046<.001<.00136
COADMMP14 →+0.399+0.027<.001<.00136
COADRPL5 →-0.171-0.028<.001<.00135
COADSFRP2 →+1.217+0.031<.001<.00135
OVC1R →+0.806+0.058<.001<.00135
OVC1S →+0.579+0.045<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018210 vs LOX — OV

Per-sample scatter of Peptidyl-threonine modification activity vs LOX in OV.

Explore this scatter interactively →

Exploration